What Is GGT (Gamma-Glutamyl Transferase)? Normal vs Optimal Range Explained

The lab reference range for GGT extends to 65 U/L, but this ceiling hides a massive amount of metabolic information. GGT above 20 U/L independently predicts cardiovascular disease, type 2 diabetes, metabolic syndrome, and all-cause mortality—well before the lab flags anything as abnormal. The CTD catalogs over 5,400 compound interactions with GGT-related genes, reflecting the enzyme's role as a frontline sensor of oxidative stress and toxic exposure. GGT's primary physiological function is breaking down extracellular glutathione—the body's master antioxidant—to recycle its amino acid components. When oxidative stress increases from alcohol, medications, environmental toxins, or metabolic disease, the body upregulates GGT production to maintain glutathione recycling capacity. A GGT of 40 U/L—"perfectly normal" by lab standards—already indicates the body is working harder to manage its oxidative burden.

PubMed indexes over 35,000 publications on GGT, and the most significant recent finding is its power as a cardiovascular risk predictor. Large population studies demonstrate that GGT above 25 U/L in men and 15 U/L in women is associated with significantly increased risk of heart disease, stroke, and diabetes—independent of alcohol consumption, body weight, and traditional risk factors. GGT is uniquely sensitive to alcohol use (even moderate consumption raises GGT), fatty liver disease, medication toxicity, and bile duct obstruction. When GGT is elevated alongside normal ALT and AST, it often points toward alcohol exposure or early fatty liver before hepatocellular damage has occurred, making GGT an earlier and more sensitive indicator of liver burden than standard liver enzymes.

FAERS documents over 19,000 adverse event reports involving hepatic enzyme elevation, with GGT being one of the most sensitive early indicators of medication-induced liver stress. Anticonvulsants (phenytoin, carbamazepine) are potent GGT inducers—GGT can rise to 2–3 times the upper limit without indicating liver damage. Statins, antifungals, and acetaminophen at high doses also elevate GGT. The clinical value of serial GGT monitoring is distinguishing benign enzyme induction (stable elevation) from progressive liver injury (rising GGT with rising ALT/AST). A GGT that continues climbing over weeks despite stable medication dosing warrants investigation, while a stable elevated GGT on an enzyme-inducing anticonvulsant is an expected pharmacological effect.